Robert advises in the physics, engineering and electronics fields, with specialisms in the fields of medical devices, non-conventional manufacturing, MEMs, micropower generation and rapid prototyping. Prior to joining the intellectual property profession he completed a Mechanical Engineering MEng degree and a PhD in nuclear batteries at the University of Birmingham.
Robert works with a broad range of clients including multi-national corporations, universities, SMEs and lone inventors. His practice includes patent drafting and prosecution, due diligence, freedom to operate opinions and oppositions and appeals work before the EPO. In recent years the majority of his time has been spent working on oppositions and appeals before the EPO.
Robert graduated from the University of Birmingham in 2010 with a First Class MEng degree in Mechanical Engineering. He then successfully researched a PhD in Nuclear Batteries at the same university. Robert's PhD research involved elements of electronics, optics and physics and entailed designing, manufacturing, testing and modelling nuclear batteries. His undergraduate and postgraduate studies have provided him with a broad understanding of mechanics as well as specialised knowledge of topics including MEMs, rapid prototyping and micro-power generation.
Robert joined the intellectual property profession, in HGF’s Birmingham office, in July 2014 as a trainee patent attorney and qualified as a UK and European patent attorney in 2018. In his spare time Robert enjoys playing squash and travelling.
1st Class in Mechanical Engineering at the University of Birmingham
in Nuclear Batteries at the University of Birmingham
October 21st 2020
January 1st 1970
Managing Intellectual Property IP Stars 2021, comprising the highly recommended IP professionals, has now been published. HGF is delighted to have 14 European attorneys listed. IP STARS is the leading …Read article
Pharmaceutical and biotechnology patent applications also make top 10 most patented. Recent statistics published by the EPO show that a total of 14,295 European patent applications were filed in 2020 …Read article
The 2021 EPO Guidelines provide much needed guidance on how to protect antibodies in Europe. Biological drugs including therapeutic antibodies have become increasingly important to the pharmaceutical industry. The European …Read article
Opportunities for additional pharmaceutical product patent protection in Europe, based on the use of a drug to treat a patient exhibiting a biomarker indicative of drug response. Recent years have …Read article
Exploring the growth of patents for connected medical devices, and how best to protect them. The Internet of Things (IoT) is expected to change our lives by creating a connected …Read article
To waive, or not to waive, that is the question. The earliest identified date of a patient presenting with symptoms of a “novel coronavirus” in Wuhan, China is reported to …Read article
HGF in Europe and Knobbe Martens in the US are holding a joint webinar on 9th June. In this webinar we will explore considerations for implementing an effective strategy to …Event details
If you would like to discuss how HGF could help you, contact one of our IP specialists.